We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYN icon
1051
Kayne Anderson Energy Infrastructure Fund
KYN
$2.52B
– –
-18,479
Closed -$320K
LYTS icon
1052
LSI Industries
LYTS
$853M
– –
-257,240
Closed -$3.14M
MBI icon
1053
MBIA
MBI
$288M
– –
-29,774
Closed -$193K
MCR
1054
DELISTED
MFS Charter Income Trust
MCR
– –
-27,094
Closed -$206K
MDGL icon
1055
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-914
Closed -$11K
MDXG icon
1056
MiMedx Group
MDXG
$626M
– –
-236,627
Closed -$2.22M
MMSI icon
1057
Merit Medical Systems
MMSI
$4.43B
– –
-190,461
Closed -$3.54M
MOG.A icon
1058
Moog Inc Class A
MOG.A
$13B
– –
-32,470
Closed -$1.97M
MTX icon
1059
Minerals Technologies
MTX
$2.31B
– –
-33,008
Closed -$1.51M
MTZ icon
1060
MasTec
MTZ
$26.7B
– –
-109,867
Closed -$1.91M
NCMI icon
1061
National CineMedia
NCMI
$354M
– –
-3,695
Closed -$580K
NCV
1062
Virtus Convertible & Income Fund
NCV
$374M
– –
-19,721
Closed -$437K
NCZ
1063
Virtus Convertible & Income Fund II
NCZ
$289M
– –
-22,091
Closed -$446K
NEO icon
1064
NeoGenomics
NEO
$1.81B
– –
-10,114
Closed -$80K
NTGR icon
1065
NETGEAR
NTGR
$669M
– –
-90,573
Closed -$3.8M
NVAX icon
1066
Novavax
NVAX
$1.23B
– –
-629
Closed -$106K
NWPX icon
1067
NWPX Infrastructure Inc
NWPX
$1.25B
– –
-36,786
Closed -$412K
NXDT
1068
NexPoint Diversified Real Estate Trust
NXDT
$281M
– –
-19,106
Closed -$391K
OCFC icon
1069
OceanFirst Financial
OCFC
$1.7B
– –
-31,964
Closed -$640K
OLP
1070
One Liberty Properties
OLP
$548M
– –
-18,327
Closed -$393K
ONTO icon
1071
Onto Innovation
ONTO
$13.6B
– –
-40,724
Closed -$617K
OSIS icon
1072
OSI Systems
OSIS
$3.57B
– –
-13,942
Closed -$1.24M
OXSQ icon
1073
Oxford Square Capital
OXSQ
$151M
– –
-55,951
Closed -$340K
PATK icon
1074
Patrick Industries
PATK
$2.8B
– –
-27,999
Closed -$541K
PEBO icon
1075
Peoples Bancorp
PEBO
$1.45B
– –
-12,433
Closed -$234K
41 42
43
44 45

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.